STEPHANIE PASCALE: Open Payments
NPI 1396209326 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,712 in 248 payments from 23 companies in 2025. Trend: 2023 $12,259 · 2024 $15,906 · 2025 $18,712
Speaker / faculty: $10,824Food & beverage: $5,898Consulting: $1,125Travel & lodging: $714Education: $151
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 34 | $12,829 |
| Janssen Biotech, Inc. | 37 | $1,949 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $604 |
| ABBVIE INC. | 25 | $522 |
| Novartis Pharmaceuticals Corporation | 21 | $359 |
| Incyte Corporation | 13 | $353 |
| Amgen Inc. | 12 | $310 |
| Regeneron Healthcare Solutions, Inc. | 12 | $304 |
| Lilly USA, LLC | 13 | $285 |
| Arcutis Biotherapeutics, Inc. | 10 | $230 |
Products named: DUPIXENT, TREMFYA, OTEZLA, RINVOQ, ILUMYA, OPZELURA, EBGLYSS, Zoryve.
Industry payments across NC — which companies pay providers there.
